Table:1India Specialty Drug Distribution Market: Industry Outlook
Table:2India Specialty Drug Distribution Market: ANALYSIS
Table:3India Specialty Drug Distribution Market: Competitors Mapping & Benchmarking
Table:4India Specialty Drug Distribution Market: Major Market Players, Revenue-2021
Table:5India Specialty Drug Distribution Market: Competitive Dashboard- Vendor Mapping
Table:6India Specialty Drug Distribution Market: Market Share Analysis
Table:7India Specialty Drug Distribution Market Size (US$ Mn), by Type, 2018-2031
Table:8India Specialty Drug Distribution Market (US$ Mn), by Application, 2018-2031
Table:9India Specialty Drug Distribution Market (US$ Mn), by Application, 2018-2031
Table:10India Specialty Drug Distribution Market Size (US$ Mn), by Distribution Channel, 2018-2031
Table:11India Specialty Drug Distribution Market (US$ Mn), by Location, 2018-2031
Table:12India Specialty Drug Distribution Market Size (US$ Mn), by region, 2018-2031
Table:13India Specialty Drug Distribution Market Size (US$ Mn), by region, 2018-2031
Table:14Amgen: PRODUCTS FEATURES
Table:15Amgen: Financial Analysis
Table:16AbbVie, Inc.: PRODUCTS FEATURES
Table:17AbbVie, Inc.: RECENT DEVELOPMENT
Table:18AbbVie, Inc: Financial Analysis
Table:19Bharat Serums and Vaccines Limited: PRODUCTS FEATURES
Table:20Bharat Serums and Vaccines Limited: Financial Analysis
Table:21Novartis AG: PRODUCTS FEATURES
Table:22Novartis AG.: APPLICATIONS
Table:23Novartis AG: Financial Analysis
Table:24Merck & Co., Inc.: PRODUCTS FEATURES
Table:25Merck & Co., Inc.: APPLICATIONS
Table:26Merck & Co., Inc.: Financial Analysis
Table:27Astellas Pharma India Pvt. Ltd.: PRODUCTS FEATURES
Table:28Astellas Pharma India Pvt. Ltd.: APPLICATIONS
Table:29Serum Institute of India Pvt. Ltd.: Recent Developments
Table:30Divis Laboratories: PRODUCTS Brands
Table:31Divis Laboratories: Financial Analysis
Table:32Lupin: PRODUCTS/SERVICE
Table:33Lupin: APPLICATIONS
Table:34Lupin: Financial Analysis
Table:35Cipla: PRODUCTS/SERVICE
Table:36Cipla: APPLICATIONS
Table:37Cipla: Financial Analysis
Table:38Eisai: Recent Developments
Table:39Eisai: PRODUCTS/SERVICE
Table:40Eisai: DESCRIPTION
Table:41Eisai: Financial Analysis
Table:42Glenmark Pharmaceuticals: Products Brands
Table:43Glenmark Pharmaceuticals: APPLICATIONS
Table:44Glenmark Pharmaceuticals: Financial Analysis
Table:45IMS Medi: APPLICATIONS
Table:46IMS Medi: Locations
Table:47Entero Healthcare Solutions Private Limited: PRODUCTS FEATURES
Table:48Entero Healthcare Solutions Private Limited: PRESENCE IN INDIA
Table:49Torrent Pharmaceuticals Ltd: PRODUCTS FEATURES
Table:50Torrent Pharmaceuticals Ltd: APPLICATIONS
Table:51Torrent Pharmaceuticals Ltd: Financial Analysis
Table:52Sun Pharmaceutical Industries Ltd: Key Developments Products
Table:53Sun Pharmaceutical Industries Ltd: APPLICATIONS
Table:54Sun Pharmaceutical Industries Ltd: Financial Analysis
Table:55Dr. Reddy’s Laboratories Ltd: Key Developments Products
Table:56Dr. Reddy’s Laboratories Ltd: APPLICATIONS
Table:57Dr. Reddy’s Laboratories Ltd: Financial Analysis
Table:58Aurobindo Pharmaceuticals: Strategic Outlook Products
Table:59Aurobindo Pharmaceuticals: APPLICATIONS
Table:60Aurobindo Pharmaceuticals: Financial Analysis
Table:61Zydus Lifesciences Limited: PRODUCTS FEATURES
Table:62Zydus Lifesciences Limited: APPLICATIONS
Table:63Zydus Lifesciences Limited: Financial Analysis
Table:64Aknamed: Vaccines – Services – By brand
Table:65Aknamed: Pharmaceuticals– Services – By Brand
Table:66Aknamed: Surgical & Consumables– Services – By Brand
Table:67Aark Pharmaceuticals: Specialty Drug Manufacturers
Table:68Arlak Biotech: PRODUCTS FEATURES
Table:69Arlak Biotech: APPLICATIONS
Table:70Intas Pharmaceuticals Ltd.: PRODUCTS FEATURES
Table:71Intas Pharmaceuticals Ltd.: APPLICATIONS
Table:72IMS Medi: APPLICATIONS
Table:73IMS Medi: Locations
Table:74Entero Healthcare Solutions Private Limited: PRODUCTS FEATURES
Table:75Prime Health: PRODUCTS FEATURES
Table:76Prime Health: APPLICATIONS
Table:77Biotic Healthcare: PRODUCTS FEATURES
Table:78Biotic Healthcare: APPLICATIONS
Table:79Bristol Myer Squib: PRODUCTS Description
Table:80Bristol Myer Squib: PRODUCTS Description
Table:81Bristol Myer Squib: PRODUCTS Description
Table:82Bristol Myer Squib: Financial Analysis
Table:833S Corporation: PRODUCTS Manufacturers
Table:843S Corporation: APPLICATIONS
Table:85D.Vijay Pharma: PRODUCTS FEATURES
Table:86D.Vijay Pharma: APPLICATIONS
Table:87Feron Healthcare: PRODUCTS FEATURES
Table:88Feron Healthcare: APPLICATIONS
Table:89Gaia Pharmaceutical Trade: PRODUCTS FEATURES
Table:90Gaia Pharmaceutical Trade: APPLICATIONS
Table:91GNova Biotech: PRODUCTS FEATURES
Table:92GNova Biotech: APPLICATIONS
Table:93Vardhman Health Specialities Pvt. Ltd.: PRODUCTS FEATURES
Table:94Ikris Pharma: PRODUCTS FEATURES
Table:95Ikris Pharma: APPLICATIONS
Table:96Jay-Pharma: PRODUCTS FEATURES
Table:97Jay-Pharma: APPLICATIONS
Table:98Meher Distributors Pvt. Ltd.: PRODUCTS FEATURE
Table:99Meher Distributors Pvt. Ltd.: APPLICATIONS
Table:100Pax Healthcare: PRODUCTS FEATURES
Table:101Pax Healthcare: APPLICATIONS
Table:102Sanify Healthcare: PRODUCTS FEATURES
Table:103Sanify Healthcare: APPLICATIONS
Table:104Servocare Lifesciences: PRODUCTS FEATURES
Table:105Servocare Lifesciences: APPLICATIONS
Table:106Shubham Pharmaceutical: PRODUCTS FEATURES
Table:107Shubham Pharmaceutical: APPLICATIONS
Table:108Swisschem Healthcare: PRODUCTS FEATURES
Table:109Swisschem Healthcare: APPLICATIONS
Figure: 1India Specialty Drug Distribution Market Size, By Value, 2018-2031 (USD Million)
Figure: 2India Specialty Drug Distribution Market Size, By YoY Growth, 2023-2031 (%)
Figure: 3North India dominates the Specialty Drug Distribution Market (2022)
Figure: 4Specialty Drug Distribution Market Share 2022 & 2031 by North India
Figure: 5Value Chain Overview of the India Specialty Drug Distribution Market
Figure: 6Supply Chain – India Specialty Drug Distribution Market
Figure: 7Porter’s Five Force Overview of the India Specialty Drug Distribution Market
Figure: 8India: Market Dynamics
Figure: 9India: Impact Analysis
Figure: 10Trade in India Pharmaceuticals (In Million)
Figure: 11Region wise India’s Pharma exports FY 2019-20
Figure: 12India: Market Concentration Rate (2022)
Figure: 13India: Market Share Analysis
Figure: 14India: Major states for Pharmaceuticals
Figure: 15India: Market Revenue Estimates and Forecast (US$ Mn), 2018 – 2031
Figure: 16India Specialty Drug Distribution Market, By Type, CAGR (%), 2023-2031
Figure: 17India Specialty Drug Distribution Market Share (%), by Type, 2022
Figure: 18India Specialty Drug Distribution Market Share (%), by Type, 2031
Figure: 19India Specialty Drug Distribution Market, By Application, CAGR (%), 2023-2031
Figure: 20India Specialty Drug Distribution Market Share (%), by Application, 2021
Figure: 21India Specialty Drug Distribution Market Share (%), by Application, 2031
Figure: 22India Specialty Drug Distribution Market, By Distribution Channel, CAGR (%), 2023-2031
Figure: 23India Specialty Drug Distribution Market Share (%), by Distribution Channel, 2022
Figure: 24India Specialty Drug Distribution Market Share (%), by Distribution Channel, 2031
Figure: 25India Specialty Drug Distribution Market, By Location, CAGR (%), 2023-2031
Figure: 26India Specialty Drug Distribution Market Share (%), by Location, 2022
Figure: 27India Specialty Drug Distribution Market Share (%), by Location, 2031
Figure: 28India Specialty Drug Distribution Market Share (%), by region, 2022
Figure: 29India Specialty Drug Distribution Market Share (%), by region, 2031
Figure: 30Amgen: Business Revenue Segmentation, 2021
Figure: 31Amgen: Geographical Revenue Segmentation, 2021
Figure: 32AbbVie, Inc.: Business Revenue Segmentation, 2021
Figure: 33AbbVie, Inc.: Geographical Revenue Segmentation, 2021
Figure: 34Novartis AG: Business Revenue Segmentation, 2021
Figure: 35Novartis AG: Geographical Revenue Segmentation, 2021
Figure: 36Merck & Co., Inc.: Business Product Revenue Segmentation, 2021
Figure: 37Merck & Co., Inc.: Geographical Revenue Segmentation, 2021
Figure: 38Divis Laboratories: Geographical Revenue Segmentation, 2021
Figure: 39Lupin: Geographical Revenue Segmentation, 2021
Figure: 40Cipla: Business Revenue Segmentation, 2021
Figure: 41Cipla: Geographical Revenue Segmentation, 2021
Figure: 42Eisai: Business Revenue Segmentation, 2021
Figure: 43 Eisai: Geographical Revenue Segmentation, 2021
Figure: 44Glenmark Pharmaceuticals: Geographical Revenue Segmentation, 2020
Figure: 45Torrent Pharmaceuticals Ltd: Business Revenue Segmentation, 2021
Figure: 46Torrent Pharmaceuticals Ltd: Geographical Revenue Segmentation, 2021
Figure: 47Sun Pharmaceutical Industries Ltd: Geographical Revenue Segmentation, 2021
Figure: 48Dr. Reddy’s Laboratories Ltd: Business Product Revenue Segmentation, 2021
Figure: 49Dr. Reddy’s Laboratories Ltd: Geographical Revenue Segmentation, 2021
Figure: 50Aurobindo Pharmaceuticals: Geographical Revenue Segmentation, 2021
Figure: 51Zydus Lifesciences Limited: Business Revenue Segmentation, 2021
Figure: 52Zydus Lifesciences Limited: Geographical Revenue Segmentation, 2021
Figure: 53Bristol Myer Squib: Product Revenue Segmentation, 2021
Figure: 54Bristol Myer Squib: Geographical Revenue Segmentation, 2021
.png)
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
| Report ID: AA0223359 | Delivery: 2 to 4 Hours 
